Jefferson Health

Physician Profile

Margaret Kasner, MD

Jefferson University Physician

Academic Title: Assistant Professor

Specialties
Medical Oncology
Medical Oncology - Hematologic Malignancies
Medical Oncology - Leukemia/Lymphoma

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
925 Chestnut Street
Suite 420A
Philadelphia PA 19107
Phone: (215) 955-8874
Fax: (215) 955-2340

Medical Services

Board Certifications

  • Medical Oncology
  • Internal Medicine
  • Hematology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital

Notes

Dr. Kasner also specializes in Stem Cell Transplantation.

Education

  • University of Pennsylvania School of Medicine, Medical School

Residency

  • Hospital of the University of Pennsylvania

Fellowship

  • Hospital of the University of Pennsylvania

Recent Publications

Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization

Acute myeloid leukemia patients’ clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts

A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation

Polo-like kinase and its inhibitors: Ready for the match to start?

A two-step approach to myeloablative haploidentical transplantation: Low nonrelapse mortality and high survival confirmed in patients with earlier stage disease

Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors

Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation

Treatment of adult ALL: More questions than answers

Treatment of adult ALL: more questions than answers.

Single-cell pharmacodynamic monitoring of S6 ribosomal protein phosphorylation in AML blasts during a clinical trial combining the mTOR inhibitor sirolimus and intensive chemotherapy

A2-step approach to myeloablative haploidentical stem cell transplantation: A phase 1/2 trial performed with optimized T-cell dosing

Novel targets for treatment of adult acute lymphocytic leukemia

A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia

Update on the therapy for myelodysplastic syndrome

Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality

Increased cerebral blood flow after leukapheresis for acute myelogenous leukemia